QA: Gossamer Bio Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728117_2024_Gossamer_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728117, Gossamer Bio Inc

  xvar xval
0 AssetsCurrent 306,519,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,648,000
3 remainder_Assets 3,749,000
4 LiabilitiesCurrent 51,598,000
5 LiabilitiesNoncurrent 958,000
6 remainder_Liabilities 196,591,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 38,455,000
9 ResearchAndDevelopmentExpense 135,304,000
10 remainder_Expenses 10,000,000
11 remainder_Revenues 0
12 remainder_NetIncome 3,942,000
13 remainder_ComprehensiveNetIncome 224,000
  yvar yval
0 Assets 311,916,000
1 Liabilities 249,147,000
2 Expenses 183,759,000
3 Revenues 0
4 StockholdersEquity 62,769,000
5 NetIncome -179,817,000
6 ComprehensiveNetIncome -179,705,000
7 BaseVar 374,494,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.153
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution